Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 8

1.

Vaccinia Virus LC16m8∆ as a Vaccine Vector for Clinical Applications.

Kidokoro M, Shida H.

Vaccines (Basel). 2014 Oct 17;2(4):755-71. doi: 10.3390/vaccines2040755. Review.

2.

Motor palsies of cranial nerves (excluding VII) after vaccination: reports to the US Vaccine Adverse Event Reporting System.

Woo EJ, Winiecki SK, Ou AC.

Hum Vaccin Immunother. 2014;10(2):301-5. doi: 10.4161/hv.27032. Epub 2013 Nov 14.

3.

Can vaccinia virus be replaced by MVA virus for testing virucidal activity of chemical disinfectants?

Rabenau HF, Rapp I, Steinmann J.

BMC Infect Dis. 2010 Jun 23;10:185. doi: 10.1186/1471-2334-10-185.

4.

Demographic and clinical factors associated with response to smallpox vaccine in preimmunized volunteers.

Bossi P, Gay F, Fouzai I, Combadière B, Brousse G, Lebrun-Vignes B, Crance JM, Autran B, Garin D.

PLoS One. 2008;3(12):e4087. doi: 10.1371/journal.pone.0004087. Epub 2008 Dec 31.

5.

Encephalitis after secondary smallpox vaccination.

Melekhin VV, Karem KL, Damon IK, Bloch KC.

Clin Infect Dis. 2009 Jan 1;48(1):e1-2. doi: 10.1086/595555.

6.

Coadministration of cidofovir and smallpox vaccine reduced vaccination side effects but interfered with vaccine-elicited immune responses and immunity to monkeypox.

Wei H, Huang D, Fortman J, Wang R, Shao L, Chen ZW.

J Virol. 2009 Jan;83(2):1115-25. doi: 10.1128/JVI.00984-08. Epub 2008 Nov 12.

7.

Differential antigen requirements for protection against systemic and intranasal vaccinia virus challenges in mice.

Kaufman DR, Goudsmit J, Holterman L, Ewald BA, Denholtz M, Devoy C, Giri A, Grandpre LE, Heraud JM, Franchini G, Seaman MS, Havenga MJ, Barouch DH.

J Virol. 2008 Jul;82(14):6829-37. doi: 10.1128/JVI.00353-08. Epub 2008 Apr 30.

Supplemental Content

Support Center